InnovaRx Innova Health Strategies
Pricing Sign in

E24.9

Cushing's syndrome, unspecified

Billable FY2026 2025-10-01 → 2026-09-30
This is the unspecified option. 6 more specific codes sit alongside it. Worth checking whether the documentation supports one of them.
Exclusions 4 never code together
E24code
Excludes1
  • congenital adrenal hyperplasia (E25.0)E25.0
E20-E35block
Excludes1
  • galactorrhea (N64.3)N64.3
  • gynecomastia (N62)N62
E00-E89chapter
Excludes1
  • transitory endocrine and metabolic disorders specific to newborn (P70-P74)P70-P74

Excludes1 — never code together. The excluded condition and this one are mutually exclusive.

Instructional notes 1
E00-E89chapter
Notes
  • All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.E05.8E07.0E16-E31E34.-
Index entries leading here 5
  • Hypersecretion
  • Cushing's
    • syndrome or disease E24.9
  • Syndrome — see also Disease
  • Myopathy G72.9
    • in (due to)
      • Cushing's syndrome E24.9
      • hyperadrenocorticism E24.9
  • Hyperadrenocorticism E24.9
Alongside this code 6 same parent — E24
E24.0 Pituitary-dependent Cushing's disease E24.1 Nelson's syndrome E24.2 Drug-induced Cushing's syndrome E24.3 Ectopic ACTH syndrome E24.4 Alcohol-induced pseudo-Cushing's syndrome E24.8 Other Cushing's syndrome
Additional references
AHA Coding Clinic® Licence required

Official coding advice for this code. Published by the American Hospital Association. Not included in this installation.

Risk adjustment

CMS22HCC23 ESRD21HCC23 ESRD24HCC23 RX08HCC43

Presence is a property of the code. Untick a model to hide it everywhere.

This code

Billable
yes
Code set
FY2026
Parent
E24
Block
E20-E35
Siblings
6

Present FY2024–FY2027.